D-0506-2026 Class II Ongoing
FDA drug recall D-0506-2026 was initiated by Wells Pharma Of Houston LLC on Apr 1, 2026 and is designated Class II. Reason for recall: cGMP deviations. The recall status is ongoing. Affected quantity: 150 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- May 6, 2026
- Initiation Date
- Apr 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 150 syringes
Product description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Reason for recall
cGMP deviations.
Distribution pattern
U.S. Nationwide.
Code information
Lot 022326203650432; Exp Date 06/25/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0506-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026